Dr. Frank Winsett, MD

Dr. Winsett practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Winsett's NPI, 1134652993, was assigned on April 9, 2017. Dr. Winsett graduated from McGovern Medical School in 2017. Dr. Winsett holds Texas license S9629.

Dr. Winsett's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Winsett's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Winsett to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Winsett practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Winsett's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Winsett is board certified in dermatology by the American Board of Dermatology. Dr. Winsett is licensed in Texas.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, joint cyst, psoriasis, rash and scalp rash among the conditions Dr. Winsett treats.

CMS data shows 1,445 Medicare services from Dr. Winsett across 20 procedure codes in 2024, for 439 Medicare patients. Medicare paid $115,036 for them.

CMS counts 439 Medicare patients who saw Dr. Winsett in 2024. The largest group is 65 to 74, with 206 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Winsett's median patient age at 73, with 45% women.

In 2024, Dr. Winsett wrote 450 Medicare Part D claims for 250 patients. 93% of them were for generic drugs. CMS names the drug for 303 of them, across 11 drugs with 11 or more claims each, at $165,434 in total drug cost. In 2023, CMS named 203 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Winsett for performance year 2024, reported as part of a group. Dr. Winsett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 88 procedures of melanoma (skin cancer) excision by Dr. Winsett, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Winsett, published from 2017 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Skin Neoplasms, Carcinoma, Squamous Cell and Mohs Surgery. Dr. Winsett has published most often in Dermatol Online J. Dr. Winsett's most frequent co-authors are Richard F. Wagner, MD, Brent Christopher Kelly, MD and Renat Ramilevich Ahatov.

CMS Open Payments shows 9 general payments to Dr. Winsett from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $196.

Dr. Winsett graduated from McGovern Medical School in 2017.

Dr. Winsett is in network with 22 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.